Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Gynecologic 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Sarcoma 1Rectal Neoplasms 1Pancreatic Neoplasms 1Gastrointestinal Stromal Tumors 1Gallbladder Neoplasms 1Fallopian Tube Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Bile Duct Neoplasms 1Appendiceal Neoplasms 1

Interventions

pembrolizumab 10Paclitaxel 8Taxes 6Nivolumab 4Cyclophosphamide 4Cisplatin 4Carboplatin 4Polymerase Chain Reaction 3Irinotecan 3Interleukin-12 Subunit p35 3Docetaxel 3Bevacizumab 3sargramostim 2lenvatinib 2aldesleukin 2aflibercept 2Trastuzumab 2SS1(dsFv)PE38 2Radiotherapy 2Psychiatric Rehabilitation 2Methods 2Interleukin-12 2Gene Expression Profiling 2Gemcitabine 2Filgrastim 2Early Intervention, Educational 2Capecitabine 2Albumin-Bound Paclitaxel 2veliparib 1tocilizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Ovarian Epithelial × motexafin lutetium × Gastrointestinal × Clear all
NCT00087191 2013-01-16

EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase NA Terminated
30 enrolled
GastrointestinalGynecologicSarcomaThoracic

Carcinoma, Ovarian Epithelial, Appendiceal Neoplasms, Bile Duct Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Fallopian Tube Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Rectal Neoplasms, Sarcoma, Stomach Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡